249 related articles for article (PubMed ID: 26093898)
21. MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer.
Menezes ME; Shen XN; Das SK; Emdad L; Sarkar D; Fisher PB
Oncotarget; 2016 Dec; 7(49):80175-80189. PubMed ID: 27863394
[TBL] [Abstract][Full Text] [Related]
22. mda-9/Syntenin promotes metastasis in human melanoma cells by activating c-Src.
Boukerche H; Su ZZ; Prévot C; Sarkar D; Fisher PB
Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15914-9. PubMed ID: 18832467
[TBL] [Abstract][Full Text] [Related]
23. Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells.
Talukdar S; Das SK; Pradhan AK; Emdad L; Shen XN; Windle JJ; Sarkar D; Fisher PB
Oncotarget; 2016 Aug; 7(34):54102-54119. PubMed ID: 27472461
[TBL] [Abstract][Full Text] [Related]
24. MDA-9/syntenin: a positive gatekeeper of melanoma metastasis.
Das SK; Bhutia SK; Kegelman TP; Peachy L; Oyesanya RA; Dasgupta S; Sokhi UK; Azab B; Dash R; Quinn BA; Kim K; Barral PM; Su ZZ; Boukerche H; Sarkar D; Fisher PB
Front Biosci (Landmark Ed); 2012 Jan; 17(1):1-15. PubMed ID: 22201728
[TBL] [Abstract][Full Text] [Related]
25. MDA-9/Syntenin (SDCBP): Novel gene and therapeutic target for cancer metastasis.
Das SK; Maji S; Wechman SL; Bhoopathi P; Pradhan AK; Talukdar S; Sarkar D; Landry J; Guo C; Wang XY; Cavenee WK; Emdad L; Fisher PB
Pharmacol Res; 2020 May; 155():104695. PubMed ID: 32061839
[TBL] [Abstract][Full Text] [Related]
26. Expression patterns of MDA-9/syntenin during development of the mouse embryo.
Jeon HY; Das SK; Dasgupta S; Emdad L; Sarkar D; Kim SH; Lee SG; Fisher PB
J Mol Histol; 2013 Apr; 44(2):159-66. PubMed ID: 23180153
[TBL] [Abstract][Full Text] [Related]
27. Targeting tumor invasion: the roles of MDA-9/Syntenin.
Kegelman TP; Das SK; Emdad L; Hu B; Menezes ME; Bhoopathi P; Wang XY; Pellecchia M; Sarkar D; Fisher PB
Expert Opin Ther Targets; 2015 Jan; 19(1):97-112. PubMed ID: 25219541
[TBL] [Abstract][Full Text] [Related]
28. MDA-9/Syntenin regulates protective autophagy in anoikis-resistant glioma stem cells.
Talukdar S; Pradhan AK; Bhoopathi P; Shen XN; August LA; Windle JJ; Sarkar D; Furnari FB; Cavenee WK; Das SK; Emdad L; Fisher PB
Proc Natl Acad Sci U S A; 2018 May; 115(22):5768-5773. PubMed ID: 29760085
[TBL] [Abstract][Full Text] [Related]
29. MiRNA-139-3p inhibits the proliferation, invasion, and migration of human glioma cells by targeting MDA-9/syntenin.
Tian W; Wu W; Li X; Rui X; Wu Y
Biochem Biophys Res Commun; 2019 Jan; 508(1):295-301. PubMed ID: 30502089
[TBL] [Abstract][Full Text] [Related]
30. MDA-9/Syntenin: An emerging global molecular target regulating cancer invasion and metastasis.
Das SK; Sarkar D; Emdad L; Fisher PB
Adv Cancer Res; 2019; 144():137-191. PubMed ID: 31349898
[TBL] [Abstract][Full Text] [Related]
31. MDA-9/syntenin interacts with ubiquitin via a novel ubiquitin-binding motif.
Okumura F; Yoshida K; Liang F; Hatakeyama S
Mol Cell Biochem; 2011 Jun; 352(1-2):163-72. PubMed ID: 21359963
[TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus type 8 E6 oncoprotein inhibits transcription of the PDZ protein syntenin-2.
Lazić D; Hufbauer M; Zigrino P; Buchholz S; Kazem S; Feltkamp MC; Mauch C; Steger G; Pfister H; Akgül B
J Virol; 2012 Aug; 86(15):7943-52. PubMed ID: 22623796
[TBL] [Abstract][Full Text] [Related]
33. Pathways- and epigenetic-based assessment of relative immune infiltration in various types of solid tumors.
Bacolod MD; Barany F; Pilones K; Fisher PB; de Castro RJ
Adv Cancer Res; 2019; 142():107-143. PubMed ID: 30885360
[TBL] [Abstract][Full Text] [Related]
34. mda-9/Syntenin: more than just a simple adapter protein when it comes to cancer metastasis.
Sarkar D; Boukerche H; Su ZZ; Fisher PB
Cancer Res; 2008 May; 68(9):3087-93. PubMed ID: 18451132
[TBL] [Abstract][Full Text] [Related]
35. Syntenin: a novel PDZ domain-containing scaffolding protein associated with human melanoma metastasis.
Yang JB; McCarthy JB
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 32(2):204-12. PubMed ID: 17478924
[TBL] [Abstract][Full Text] [Related]
36. mda-9/syntenin: recent insights into a novel cell signaling and metastasis-associated gene.
Sarkar D; Boukerche H; Su ZZ; Fisher PB
Pharmacol Ther; 2004 Nov; 104(2):101-15. PubMed ID: 15518882
[TBL] [Abstract][Full Text] [Related]
37. Suppression of Prostate Cancer Pathogenesis Using an MDA-9/Syntenin (SDCBP) PDZ1 Small-Molecule Inhibitor.
Das SK; Kegelman TP; Pradhan AK; Shen XN; Bhoopathi P; Talukdar S; Maji S; Sarkar D; Emdad L; Fisher PB
Mol Cancer Ther; 2019 Nov; 18(11):1997-2007. PubMed ID: 31345950
[TBL] [Abstract][Full Text] [Related]
38. Genomic pathway analysis reveals that EZH2 and HDAC4 represent mutually exclusive epigenetic pathways across human cancers.
Cohen AL; Piccolo SR; Cheng L; Soldi R; Han B; Johnson WE; Bild AH
BMC Med Genomics; 2013 Sep; 6():35. PubMed ID: 24079712
[TBL] [Abstract][Full Text] [Related]
39. MDA-9/Syntenin in the tumor and microenvironment defines prostate cancer bone metastasis.
Maji S; Pradhan AK; Kumar A; Bhoopathi P; Mannangatti P; Guo C; Windle JJ; Subler MA; Wang XY; Semmes OJ; Nyalwidhe JO; Mukhopadhyay N; Paul AK; Hatfield B; Levit MM; Madan E; Sarkar D; Emdad L; Cohen DJ; Gogna R; Cavenee WK; Das SK; Fisher PB
Proc Natl Acad Sci U S A; 2023 Nov; 120(45):e2307094120. PubMed ID: 37922327
[TBL] [Abstract][Full Text] [Related]
40. mda-9/Syntenin protein positively regulates the activation of Akt protein by facilitating integrin-linked kinase adaptor function during adhesion to type I collagen.
Hwangbo C; Park J; Lee JH
J Biol Chem; 2011 Sep; 286(38):33601-12. PubMed ID: 21828040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]